No ‘Doomsday’ For US Pharma Despite Political Uncertainties, EU Industry Chief Says

 
• By Eliza Slawther
Carlos Gallardo, Stefan Oelrich and Nathalie Moll in Brussels, Belgium, June 2025

More from Pricing Debate

More from United States